South Africa halts AstraZeneca vaccine as study says it is ineffective against new Covid-19 strain

▴ South Africa halts AstraZeneca vaccine as study says it is ineffective against new Covid-19 strain
Jolt for AstraZeneca as the vaccine does not meet approval standard

South African health officials said Sunday they're pausing the country's rollout of AstraZeneca's coronavirus vaccine after a study showed it offered reduced protection from the Covid-19 variant first identified there.

During a briefing on Sunday, South Africa Minister of Health Dr Zweli Mkhize said the hold would be temporary while scientists figure out how to most effectively deploy the AstraZeneca vaccine. Mkhize said South Africa will move forward with the deployment of vaccines made by Pfizer/BioNTech and Johnson & Johnson.

Early data released Sunday suggest two doses of the Oxford/AstraZeneca Covid-19 vaccine provided only "minimal protection" against mild and moderate Covid-19 from the variant first identified in South Africa.


The study, which has not been released, included about 2,000 volunteers who were an average of 31 years old; about half received the vaccine and half received a placebo, which does nothing.
Viral neutralization against the B.1.351 variant was "substantially reduced" when compared to the earlier coronavirus strain, researchers said in a news release. The vaccine's efficacy against severe Covid-19, hospitalization and death were not assessed.
Details of the study by researchers from South Africa's University of Witwatersrand and others, as well as from the University of Oxford, were shared in a press release. The results have been submitted for peer-review and a preprint will be released soon, Oxford said.
In a statement on Sunday, an AstraZeneca spokesperson said the company is "working closely with the South African Ministry of Health on how best to support the evaluation against the severe disease of the B.1.351 variant, and start to bring this vaccine to the South African people should it prove to be successful."

Tags : #SouthAfrica #AstraZenecaVavcinehalted #CovidNewsStrain #SouthAfricaCovidStrain #DrZweliMakhije #Witwatersrand #OxfordUniversity

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026